Change in the Management of TSS

The TSS company logo, representing a change in the company's management.
We are thrilled to announce a new chapter at TSS as we bid farewell to our esteemed CEO, Niclas Ohlsson.

After 16 years of dedicated service as our Chief Executive Officer (CEO), Niclas Ohlsson has made the decision to step down to prioritize his well-being following a recent health scare. Niclas has been instrumental in shaping TSS into a leading company within the industry, and we are truly grateful for his years of hard work and leadership.

Stepping into the role of CEO is Tobias Holmer, our CTO for the past 9 years and interim CEO for the last 7 months. Tobias's wealth of experience and forward-thinking leadership have already positively impacted our organization, and we are enthusiastic about the exciting future under his guidance.

We are excited to continue our mission of delivering the highest standards in temperature monitoring solutions for the pharmaceutical industry.

Join us in wishing Niclas all the best in his future endeavors and thanking him for his remarkable contributions. Here’s to a new era of growth and success with Tobias at the helm!

__wf_reserved_inherit
Tobias Holmer, CEO

You may also be interested in

Could automating temperature excursion management hold the key to improving clinical supply processes?

There are a few key reasons why many sponsors are starting to ask whether current clinical supply processes are efficient enough.
Read moreDownload Whitepaper
An event banner for the 25th Annual Clinical Trial Supply Europe conference.

Join us at Clinical Trial Supply Europe 2024 in Barcelona

Are you in pursuit of optimizing the temperature management of your clinical trials supply chain? Get inspired by experts from the field, and learn from their experiences.
Read moreDownload Whitepaper
A clinical trial supply chain diagram over a stack of paperwork, representing the need for automation.

Future-Proofing Clinical Trials: How Sponsors Can Up-Scale Through Automation

At this year’s Clinical Trial Supply Europe event in Barcelona, TSS took center stage to discuss one of the most pressing challenges in clinical trial supply chains—temperature monitoring. Our Key Account Manager, Anita Leposa, highlighted how automation is revolutionizing temperature integrity management, reducing manual work, and ensuring compliance for global pharmaceutical sponsors.
Read moreDownload Whitepaper

You may also be interested in

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.